Specialty catheter market seen topping $10.87 billion by 2030

The specialty catheters market is projected to rise from $7.62 billion in 2026 to $10.87 billion by 2030, driven by more cardiovascular disease, more critical care use and wider adoption of minimally invasive procedures. North America held the largest share in 2025, while the latest report adds new forecasting and market-scoring tools.

Why it matters: - The specialty catheters market is tied to procedures that help doctors deliver treatment, run diagnostics and manage complex care more precisely. - Faster growth in this market signals rising demand for devices used in cardiovascular care, intensive care and surgery. - The market’s projected move toward $10.87 billion by 2030 points to continued spending on hospital capacity and procedure-specific devices.

What happened: - The Business Research Company released its Specialty Catheters Market Report 2026, covering market size, trends and global forecasts for 2026-2035. - The market grew from $6.95 billion in 2025 to an expected $7.62 billion in 2026. - The report projects the market will reach $10.87 billion by 2030. - The press release was issued in London on Aug. 27, 2026. - The company provided a free sample of the report. - The company also linked to the full specialty catheters market report.

The details: - Specialty catheters are slender, flexible tubes designed for targeted medical uses. - The devices support precise treatment delivery, diagnostic procedures and specific interventions in different areas of the body. - The report says growth has been driven by rising cardiovascular disease, more ICU capacity, more surgical procedures, stronger infection control focus and better hospital infrastructure. - The report expects demand to stay strong through 2030 as populations age, critical care admissions rise, surgical techniques advance and hospitals expand capacity. - The report flags rising preference for procedure-specific catheters, broader use of minimally invasive procedures, multi-lumen catheter designs, expanded critical care use and more customization for clinical needs. - The report identifies cardiovascular disease as a major demand driver. - Cardiovascular disease includes coronary artery disease, hypertension and heart failure. - Higher obesity, diabetes and hypertension rates, along with aging populations and sedentary lifestyles, are increasing cardiovascular disease burden. - Specialty catheters support targeted drug delivery, angioplasty and stent placement. - The CDC reported in May 2024 that heart disease caused 702,880 deaths in the U.S. in 2022. - Global deaths attributed to heart disease are expected to reach 23 million by 2030. - North America held the largest share of the global specialty catheters market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future trend analysis.

Between the lines: - The market outlook is being shaped by both disease burden and care delivery changes, especially the shift toward more precise and less invasive procedures. - The report’s added analytics suggest buyers and suppliers are looking for more granular planning tools, not just a top-line market forecast. - North America’s leading share suggests the region remains a major demand center, but the global forecast leaves room for faster adoption in other regions as hospital systems expand.

What's next: - Demand will likely track cardiovascular case volume, ICU utilization and hospital investment in advanced procedures. - Product development is likely to stay focused on catheter customization, multi-lumen designs and procedure-specific uses. - The report positions 2030 as the next major benchmark for the market’s growth path.

The bottom line: - Specialty catheters are moving from a $7.62 billion market in 2026 toward $10.87 billion by 2030, with cardiovascular disease and minimally invasive care doing most of the work.